Organisation paid for research Program year 2025 Source: CMS Open Payments

Centricity Research Columbus

Neither a doctor nor a teaching hospital

Research payments

$206,939

328 payments

Through program year 2025, Centricity Research Columbus is reported as receiving $206,939 in research payments, across 328 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $72,375 27
2024 Research $51,426 65
2023 Research $67,065 232
2022 Research $16,073 4

Breakdown

Who paid Research payments · program years 2022–2025
  1. Novo Nordisk AS $122,354 312 payments
  2. Pfizer Inc. $26,292 3 payments
  3. AstraZeneca UK Limited $24,636 2 payments
  4. Mylan Inc. $15,451 6 payments
  5. Mylan Technologies Inc. $9,343 3 payments
  6. Amgen Inc. $8,862 2 payments
Studies the money was for Research payments · program years 2022–2025
  1. Nn9536-4512 $122,354 312 payments
  2. A Phase 3 Multicenter Parallelgroup Openlabel Study to Evaluate the Safety Tolerability and Immunogenicity of Respiratory Syncytial Virus Prefusion F Subunit Vaccine When Coadministered With Herpes Zoster Subunit Vaccine in Adults 50 Years of Age $26,292 3 payments
  3. A Phase 2a Randomized Double blind Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease $17,907 1 payment
  4. Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $15,451 6 payments
  5. Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $9,343 3 payments
  6. ASTRO P3 AD Adolescent Mono $6,883 1 payment
  7. AZD2693, Cardiovascular, Renal and Metabolism $6,729 1 payment
  8. A Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study With Re-randomization to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO) $1,978 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record